Retatrutide achieved up to 24.2% body weight reduction in 48 weeks in Phase 2, and the recently completed Phase 3 TRIUMPH-4 trial pushed that number to an unprecedented 28.7% at 68 weeks
The EMA, which is similar to the FDA, reviewed non-clinical studies, clinical trials, post-marketing surveillance, and the medical literature regarding NAOIN and semaglutide drugs, like Ozempic
Avoid excessive alcohol consumption
As a result, individuals often experience a youthful glow and improved skin texture
In a recent 2025 study using large-scale proteomic analysis of serum samples from two phase 3 clinical trials, Maretty et al
doi: 10.3389/fphar.2020.600175 Received 29 August 2020 Accepted 18 December 2020 Published 04 March 2021 Volume 11 - 2020 Edited by Predrag Sikiric, University of Zagreb, Croatia Reviewed by Na Li, Shanghai Jiao Tong University, China Gabor Varga, Semmelweis University, Hungary Updates Copyright 2021 Zhou, Lin, Cheng, Zhuo, Li, Xu, Zhao and Yang